{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:45:37Z","timestamp":1789386337947,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.ejpn.2013.01.005","type":"journal-article","created":{"date-parts":[[2013,3,7]],"date-time":"2013-03-07T21:26:12Z","timestamp":1362691572000},"page":"421-428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Tourette Syndrome and comorbid ADHD: Current pharmacological treatment options"],"prefix":"10.1016","volume":"17","author":[{"given":"Renata","family":"Rizzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"Gulisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola V.","family":"Cal\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Curatolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2013.01.005_bib1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jpsychores.2009.07.010","article-title":"The international prevalence, epidemiology, and clinical phenomenology of Tourette syndrome: a cross cultural perspective","volume":"67","author":"Robertson","year":"2009","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.ejpn.2013.01.005_bib2","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1017\/S0012162200000839","article-title":"An international perspective on Tourette syndrome: selected findings from 3,500 individuals in 22 countries","volume":"42","author":"Freeman","year":"2000","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.ejpn.2013.01.005_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00787-007-1003-7","article-title":"Tic disorders and ADHD: answers from a world-wide clinical dataset on Tourette syndrome","volume":"16","author":"Freeman","year":"2007","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.ejpn.2013.01.005_bib4","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0031-3955(05)70168-1","article-title":"Assessment and intervention for attention-deficit\/hyperactivity disorder in the schools. Lessons from the MTA study","volume":"46","author":"Swanson","year":"1999","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.ejpn.2013.01.005_bib5","doi-asserted-by":"crossref","first-page":"I25","DOI":"10.1007\/s00787-006-1004-y","article-title":"Co-existing psychiatric problems in ADHD in the ADORE cohort","volume":"1","author":"Steinhausen","year":"2006","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.ejpn.2013.01.005_bib6","doi-asserted-by":"crossref","first-page":"I\/36","DOI":"10.1007\/s00787-007-1005-5","article-title":"Executive functions in children with chronic tic disorders with\/without ADHD\u2014new insights","volume":"16","author":"Roessner","year":"2007","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.ejpn.2013.01.005_bib7","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/mds.23434","article-title":"Clinical correlates of quality of life in Tourette syndrome","volume":"26","author":"Eddy","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.ejpn.2013.01.005_bib8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.braindev.2006.12.003","article-title":"Disentangling the effects of Tourette syndrome and attention deficit hyperactivity disorder on cognitive and behavioral phenotypes","volume":"29","author":"Rizzo","year":"2007","journal-title":"Brain Dev"},{"issue":"Suppl. 1","key":"10.1016\/j.ejpn.2013.01.005_bib9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00787-007-1002-8","article-title":"Comorbidity of tic disorders & ADHD: conceptual and methodological considerations","volume":"16","author":"Banaschewski","year":"2007","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.ejpn.2013.01.005_bib10","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaac.2010.10.004","article-title":"Familiality of Tourette syndrome, obsessive-compulsive disorder, and attention-deficit\/hyperactivity disorder: heritability analysis in a large sib-pair sample","volume":"50","author":"Mathews","year":"2011","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.ejpn.2013.01.005_bib11","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1097\/00004583-199309000-00025","article-title":"Familial relationship between Gilles de la Tourette\u2019s syndrome, attention deficit disorder, learning disabilities, speech disorders, and stuttering","volume":"32","author":"Pauls","year":"1993","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.ejpn.2013.01.005_bib12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1126\/science.1116502","article-title":"Sequence variants in SLITRK1 are associated with Tourette's syndrome","volume":"310","author":"Abelson","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ejpn.2013.01.005_bib13","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.psychres.2012.04.034","article-title":"Catecholamine-related gene expression in blood correlates with tic severity in Tourette syndrome","volume":"30","author":"Gunther","year":"2012","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.ejpn.2013.01.005_bib14","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ejpn.2012.01.009","article-title":"The neurobiology and genetics of Attention-Deficit\/Hyperactivity Disorder (ADHD): what every clinician should know","volume":"16","author":"Cortese","year":"2012","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.ejpn.2013.01.005_bib15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ejpn.2008.06.003","article-title":"The neurobiology of attention deficit\/hyperactivity disorder","volume":"13","author":"Curatolo","year":"2009","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.ejpn.2013.01.005_bib16","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1177\/08830738060210080701","article-title":"Attention-deficit hyperactivity disorder (ADHD) comorbidity: a case for \"pure\" Tourette syndrome?","volume":"21","author":"Denckla","year":"2006","journal-title":"J Child Neurol"},{"key":"10.1016\/j.ejpn.2013.01.005_bib17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.braindev.2009.01.005","article-title":"Association between Tourette syndrome and comorbidities in Japan","volume":"32","author":"Kano","year":"2010","journal-title":"Brain Dev"},{"key":"10.1016\/j.ejpn.2013.01.005_bib18","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1097\/WNR.0b013e3283174415","article-title":"Reduced white matter integrity in attention deficit hyperactivity disorder","volume":"19","author":"Hamilton","year":"2008","journal-title":"Neuroreport"},{"key":"10.1016\/j.ejpn.2013.01.005_bib19","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/sj.npp.1301528","article-title":"Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in\u00a0vivo neurochemistry study with PET","volume":"33","author":"Wong","year":"2008","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.ejpn.2013.01.005_bib20","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1192\/bjp.bp.109.071050","article-title":"Psychosocial outcome and psychiatric comorbidity in older adolescents with Tourette syndrome: controlled study","volume":"197","author":"Gorman","year":"2010","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.ejpn.2013.01.005_bib21","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/archderm.140.12.1520","article-title":"Statistical significance and clinical relevance the importance of power in clinical trials in dermatology","volume":"140","author":"Bhardwaj","year":"2004","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.ejpn.2013.01.005_bib22","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/archdischild-2011-300585","article-title":"The Gilles de La tourette syndrome: the current status","volume":"97","author":"Robertson","year":"2012","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"10.1016\/j.ejpn.2013.01.005_bib23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00787-011-0163-7","article-title":"European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment","volume":"20","author":"Roessner","year":"2011","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.ejpn.2013.01.005_bib24","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jpsychores.2008.03.007","article-title":"The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 2: tentative explanations for differing prevalence figures in GTS, including the possible effects of psychopathology, aetiology, cultural differences, and differing phenotypes","volume":"65","author":"Robertson","year":"2008","journal-title":"J Psychosom Res"},{"issue":"12","key":"10.1016\/j.ejpn.2013.01.005_bib25","first-page":"00161","article-title":"Systematicreview: pharmacological treatment of ticdisorders \u2013 efficacy of antipsychotic and alpha-2adrenergicagonistagents","author":"Weisman","year":"2012","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.ejpn.2013.01.005_bib26","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/brain\/123.3.425","article-title":"Tourette syndrome, associated conditions and the complexities of treatment","volume":"123","author":"Robertson","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.ejpn.2013.01.005_bib27","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/archpsyc.1991.01810280040006","article-title":"Clonidine treatment of Gilles de la Tourette's syndrome","volume":"48","author":"Leckman","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.ejpn.2013.01.005_bib28","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1212\/WNL.58.4.527","article-title":"Treatment of ADHD in children with tics: a randomized controlled trial","volume":"58","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2013.01.005_bib29","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1542\/peds.95.1.74","article-title":"The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine","volume":"95","author":"Singer","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejpn.2013.01.005_bib30","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/7854_2011_125","article-title":"ADHD: current and future therapeutics","volume":"9","author":"Heal","year":"2012","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.ejpn.2013.01.005_bib31","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1176\/appi.ajp.158.7.1067","article-title":"A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder","volume":"158","author":"Scahill","year":"2001","journal-title":"Am J\u00a0Psychiatry"},{"key":"10.1016\/j.ejpn.2013.01.005_bib32","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1097\/CHI.0b013e3181b26e9f","article-title":"Meta-analysis: treatment of attention-deficit\/hyperactivity disorder in children with comorbid tic disorders","volume":"48","author":"Bloch","year":"2009","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.ejpn.2013.01.005_bib33","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1017\/S0012162206001290","article-title":"First-onset tics in patients with attention-deficit-hyperactivity disorder: impact of stimulants","volume":"48","author":"Roessner","year":"2006","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.ejpn.2013.01.005_bib34","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/00004583-199705000-00008","article-title":"Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose","volume":"36","author":"Castellanos","year":"1997","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.ejpn.2013.01.005_bib35","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/chi.0b013e31805c0860","article-title":"Immediate-release methylphenidate for ADHD in children with comorbid chronic multiple tic disorder","volume":"46","author":"Gadow","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.ejpn.2013.01.005_bib36","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1001\/archpsyc.1995.03950180030005","article-title":"Efficacy of methylphenidate for attention-deficit hyperactivity disorder in children with tic disorder","volume":"52","author":"Gadow","year":"1995","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.ejpn.2013.01.005_bib37","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archpsyc.56.4.330","article-title":"Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder","volume":"56","author":"Gadow","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.ejpn.2013.01.005_bib38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1089\/cap.2010.0146","article-title":"Modulation of attention-deficit\/hyperactivity disorder symptoms by short- and long-actingmethylphenidate over the course of a day","volume":"22","author":"G\u00fcnther","year":"2012","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.ejpn.2013.01.005_bib39","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/cap.2010.0032","article-title":"Testing tic suppression: comparing the effects of dexmethylphenidate to No medication in children and adolescents with attention-deficit\/hyperactivity disorder and Tourette's disorder","volume":"20","author":"Lyon","year":"2010","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.ejpn.2013.01.005_bib40","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1089\/cap.2006.16.713","article-title":"Atomoxetine treatment in children and adolescents with attention-deficit hyperactivity disorder: what are the long-term health-related quality-of-lifeoutcomes?","volume":"16","author":"Perwien","year":"2006","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.ejpn.2013.01.005_bib41","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.neuropharm.2005.11.022","article-title":"Effect of the attention deficit\/hyperactivity disorder drug atomoxetine onextracellular concentrations of norepinephrine and dopamine in several brainregions of the rat","volume":"50","author":"Swanson","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejpn.2013.01.005_bib42","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1212\/01.wnl.0000188869.58300.a7","article-title":"Atomoxetine treatment in children and adolescents with ADHD and comorbidtic disorders","volume":"65","author":"Allen","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2013.01.005_bib43","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/1087054707306109","article-title":"Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome","volume":"11","author":"Spencer","year":"2008","journal-title":"J\u00a0Atten Disord"},{"key":"10.1016\/j.ejpn.2013.01.005_bib44","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1089\/cap.2011.0081","article-title":"Aripiprazole in children with Tourette's disorder and co-morbid attention-deficit\/hyperactivity disorder: a 12-week, open-label, preliminary study","volume":"22","author":"Masi","year":"2012","journal-title":"JChild Adolesc Psychopharmacol"},{"issue":"4","key":"10.1016\/j.ejpn.2013.01.005_bib45","first-page":"CD007990","article-title":"Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders","volume":"13","author":"Pringsheim","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejpn.2013.01.005_bib46","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00787-010-0140-6","article-title":"European\u00a0guidelines on managing adverse effects of medication for ADHD","volume":"20","author":"Graham","year":"2011","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.ejpn.2013.01.005_bib47","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s10072-011-0678-1","article-title":"Cardiovascular safety of aripiprazole and pimozide in young patients with Tourette syndrome","volume":"32","author":"Gulisano","year":"2011","journal-title":"Neurol Sci"},{"key":"10.1016\/j.ejpn.2013.01.005_bib48","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1875-9572(10)60050-2","article-title":"Tourette syndrome in children: an updated review","volume":"51","author":"Du","year":"2010","journal-title":"Pediatr Neonatol"},{"key":"10.1016\/j.ejpn.2013.01.005_bib49","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.spen.2005.12.003","article-title":"The relationship between Tourette syndrome, attention deficit hyperactivity disorder, and stimulant medication: a critical review","volume":"12","author":"Erenberg","year":"2005","journal-title":"Semin Pediatr Neurol"},{"key":"10.1016\/j.ejpn.2013.01.005_bib50","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1111\/j.1651-2227.2010.01951.x","article-title":"ADHD and epilepsy in children with Tourette syndrome: a triple comorbidity?","volume":"99","author":"Rizzo","year":"2010","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.ejpn.2013.01.005_bib51","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1093\/brain\/aws104","article-title":"Widespread abnormality of the \u03b3-aminobutyric acid-ergic system in Tourette syndrome","volume":"135","author":"Lerner","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.ejpn.2013.01.005_bib52","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.neuroimage.2010.02.049","article-title":"White-matter abnormalities in Tourettesyndromeextendbeyondmotorpathways","volume":"51","author":"Neuner","year":"2010","journal-title":"Neuroimage"},{"key":"10.1016\/j.ejpn.2013.01.005_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00787-006-0505-z","article-title":"Attention deficit hyperactivity disorder, tics and Tourette's syndrome: the relationship and treatment implications. A commentary","volume":"15","author":"Robertson","year":"2006","journal-title":"EurChild Adolesc Psychiatry"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379813000214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379813000214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T13:06:14Z","timestamp":1644498374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379813000214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S1090379813000214"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2013.01.005","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tourette Syndrome and comorbid ADHD: Current pharmacological treatment options","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2013.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}